CSF Biomarkers of Neuroinflammation in Prediction of Brain Atrophy

Abstract

Background: Inflammation is recognized as a key hallmark of Alzheimer’s disease (AD), alongside amyloid beta (Aβ) accumulation and tau pathology. Recent evidence suggests that neuroinflammatory markers in cerebrospinal fluid (CSF) are associated with progressive neurodegeneration and regional brain atrophy.

The paper